Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Hims & Hers Health CEO Andrew Dudum Posts On X "Around 100 FDA letters went out last week to companies across the industry as part of the administration's recent push on pharmaceutical marketing. We got one. A number of big pharma companies received them.....We have a long history of working with regulators to keep customers safe, and I'm looking forward to continuing that work with the FDA..."

Author: Benzinga Newsdesk | September 16, 2025 01:27pm

https://x.com/andrewdudum/status/1968002019563905092?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

Posted In: HIMS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist